dsm-firmenich AG stock (CH1216478797): valuation focus as Amsterdam shares trade around recent range

dsm-firmenich AG shares on Euronext Amsterdam traded near recent levels on 05/29/2026, keeping investor attention on valuation metrics and sector positioning after recent share buyback updates and analyst actions.

dsm-firmenich AG shares, listed on Euronext Amsterdam under the ticker DSFIR, traded close to their recent range on 05/29/2026, keeping the focus on how investors value the Swiss-headquartered nutrition, health, and beauty group in its home European markets.

The stock most recently closed at 88.22 EUR on Euronext Amsterdam, according to MarketScreener data as of 05/28/2026, positioning the company at the upper mid-band of its trading levels over the past year and reflecting ongoing investor interest in the consumer ingredients and specialty nutrition segment.

As a Swiss company with a primary listing in the Netherlands, dsm-firmenich sits at the intersection of the Swiss and Dutch equity universes, giving it exposure to European consumer and industrial investor bases that track benchmarks such as Euronext indices and Swiss large-cap peers.

Over recent weeks, the company has also reported ongoing share repurchases for employee plans and capital reduction purposes, according to a series of weekly updates referenced by MarketScreener as of May 2026, which can influence per-share metrics and is therefore relevant for current valuation work.

In Germany, the shares are also traded on platforms such as Tradegate in euro, providing an additional access point for retail investors in the DACH region who follow the name alongside other European specialty chemicals and ingredients stocks.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: DSM-Firmenich
• Sector/industry: Nutrition, health and beauty ingredients
• Headquarters/country: Kaiseraugst, Switzerland
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Nutritional ingredients, flavors and fragrances, specialty health solutions
• Home exchange/listing venue: Euronext Amsterdam (DSFIR)
• Trading currency: EUR

dsm-firmenich AG: core business model

The group primarily focuses on developing and supplying science-based nutrition, health, and beauty ingredients to consumer goods, food, and personal care companies, with revenue largely driven by long-term customer relationships in vitamins, flavors, fragrances, and related specialty solutions.

Valuation metrics and multiples for dsm-firmenich AG

Investors assessing dsm-firmenich on 05/29/2026 are closely watching traditional valuation measures such as earnings multiples and enterprise value metrics, which help position the stock against other European consumer and specialty ingredient names.

According to MarketScreener data for dsm-firmenich AG as of late May 2026, the shares trade at a forward price-earnings multiple that reflects expectations for medium-term growth in nutrition and fragrance demand, while enterprise value to EBITDA ratios and the current dividend yield sit in a band broadly comparable to a peer group of diversified consumer ingredient suppliers on Euronext and other European exchanges.

Alongside these headline valuation ratios, investors are also monitoring the impact of the ongoing share repurchase program on per-share earnings and cash flow measures, as a lower share count can support metrics even when top-line growth remains moderate, a dynamic noted in recent weekly buyback summaries highlighted by MarketScreener in May 2026.

With the stock trading in euro and the company generating revenues across several regions, currency movements between the euro, Swiss franc, and US dollar can also influence how valuation compares on a translated basis for international investors who benchmark the group against global consumer health and ingredients peers.

Conclusion

With dsm-firmenich AG trading around 88.22 EUR on Euronext Amsterdam as of late May 2026 and continuing with its share repurchase activity, valuation metrics remain a central lens through which investors interpret the stock.

The current earnings and cash flow multiples, combined with a diversified geographic and product footprint in nutrition, health, and beauty ingredients, frame the debate on how much growth and margin resilience are priced into the shares at present levels.

How these valuation indicators evolve relative to European consumer and specialty peers will likely continue to shape market sentiment toward the company in the coming months.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.